Publicacions
-
de Daniel A, Rodríguez-Lobato LG, Tovar N, Cibeira MT, Moreno DF, Oliver-Caldés A, Mario I, Lozano E, Bladé J, Rosiñol L and Fernández de Larrea C.
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma.
hemasphere . 8(5): .
-
Bardón-Cancho EJ, Marco-Sánchez JM, Benéitez-Pastor D, Payán-Pernía S, Llobet AR, Berrueco R, García-Morin M, Beléndez C, Senent L, Acosta MJO, Pleguezuelos IP, Velasco P, Collado A, Moreno-Servet M, Argilés B, de Soto IP, Del Mar Bermúdez M, Salido Fiérrez EJ, Blanco-Álvarez A, Navarro PG and Cela E.
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with ß-thalassemia.
ANNALS OF HEMATOLOGY . 103(5): 1525-1539.
-
Juan-Ribelles A, Bautista F, Cañete A, Rubio-San-Simón A, Alonso-Saladrigues A, Hladun R, Rives-Solà S, Dapena JL, Fernández JM, Lassaletta Á, Cruz-Martínez O, Ramírez-Villar G, Fuster JL, de Heredia CD, García-Ariza M, Quiroga E, Del Mar Andrés M, Verdú-Amorós J, Molinés A, Herrero B, López M, Márquez C, Toboso M, Lendínez F, Sirvent JG, Tallón M, Rodríguez G, Acha T, Moreno L and Fernández-Teijeiro A.
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer
CLINICAL & TRANSLATIONAL ONCOLOGY . : .
-
Hensel A, Bauer R, Heinrich M, Hempel G, Kelber O, Kraft K, Lehmann B, Mesegue-Meda M, Nieber K, Roether B, Rollinger JM and Wiebelitz R.
Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status - Potential Solutions - Actions Needed
Planta Medica . : .
-
Llurba E, Fàtima Crispi Brillas, Crovetto F, Youssef L, Delgado JL, Puig I, Mora J, Krofta L, Mackova K, Martinez-Varea A, Tubau A, Ruiz-Llobet A, Paya A, Prat M, Chantraine F, Comas C, Kajdy A, Lopez-Tinajero MF, Figueras-Retuerta F and Gratacós E.
Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study.
BMJ Open . 14(3): .
-
Velasco-Hernandez, T, Trincado, JL, Vinyoles, M, Closa, A, Martínez-Moreno, A, Gutiérrez-Agüera, F, Molina, O, Rodríguez-Cortez, VC, Ximeno-Parpal, P, Fernández-Fuentes, N, Petazzi, P, Beneyto-Calabuig, S, Velten, L, Romecin, P, Casquero, R, Abollo-Jiménez, F, de la Guardia, RD, Lorden, P, Bataller, A, Lapillonne, H, Stam, RW, Vives, S, Torrebadell-Burriel M, Fuster, JL, Bueno, C, Sarry, JE, Eyras, E, Heyn, H and Menéndez, P.
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
hemasphere . 8(2): .
-
Ramamoorthy S, Lebrecht D, Schanze D, Schanze I, Wieland I, Andrieux G, Metzger P, Hess M, Albert MH, Borkhardt A, Bresters D, Buechner J, Català-Temprano A, De Haas V, Dworzak M, Erlacher M, Hasle H, Jahnukainen K, Locatelli F, Masetti R, Stary J, Turkiewicz D, Vinci L, Wlodarski MW, Yoshimi A, Boerries M, Niemeyer CM, Zenker M and Flotho C.
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup
BRITISH JOURNAL OF HAEMATOLOGY . 204(2): 595-605.
-
Gutierrez-Camino A, Caron M, Richer C, Fuchs C, Illarregi U, Poncelet L, St-Onge P, Bataille AR, Tremblay-Dauphinais P, Lopez-Lopez E, Camós-Guijosa M, Ramirez-Orellana M, Astigarraga I, Lécuyer É, Bourque G, Martin-Guerrero I and Sinnett D.
CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(3): .
-
Rossig C, Pearson AD, Vassal G, Scobie N, Bird N, Blanc P, Vormoor HJ, Calkoen FG, Locatelli F, Bufalo FD, Rives-Solà S, Jacoby E, Balduzzi A, Bourquin JP and Baruchel A.
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
JOURNAL OF CLINICAL ONCOLOGY . 42(3): 253-257.
-
Molinos-Quintana Á, Alonso-Saladrigues A, Herrero B, Caballero-Velázquez T, Galán-Gómez V, Panesso M, Torrebadell-Burriel M, Delgado-Serrano J, Pérez de Soto C, Faura A, González-Martínez B, Castillo-Robleda A, Diaz-de-Heredia C, Pérez-Martínez A, Pérez-Hurtado JM, Rives-Solà S and Pérez-Simón JA.
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
FRONTIERS IN IMMUNOLOGY . 14: 1280580-1280580.